Items where Author is "<span class="person_name">Whelan, C.J.</span>"
Number of items: 9.
Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils. (2012)
Roy Pettipher,
Shan L. Vinall,
Luzheng Xue,
Graham Speight,
Elizabeth R. Townsend,
Lucien Gazi,
C.J. Whelan,
Richard E. Armer,
Mark A. Payton
and
Michael G. Hunter
Characterisation of nicotine receptors on human peripheral blood mononuclear cells (PBMC). (2009)
A. Wongsriraksa,
M. Parsons
and
C.J. Whelan
![]()
Evidence that 13–14 di-hydro, 15-keto prostaglandin D2-induced airway eosinophilia in guinea-pigs is independent of interleukin-5. (2009)
C.J. Whelan
![]()
Cannabinoid signalling in TNF-alpha induced IL-8 release. (2006)
M. E. Mormina,
S. Thakur,
A. Molleman,
C.J. Whelan
and
A. R. Baydoun
![]()
Induction of apoptosis with tobacco smoke and related products in A549 lung epithelial cells in vitro. (2006)
L. Ramage,
A.C. Jones
and
C.J. Whelan
![]()
Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids. (2003)
K. Ihenetu,
A. Molleman,
M. Parsons
and
C.J. Whelan
Nicotinic acetylcholine receptor subunits and receptor activity in the epithelial cell line HT29. (2003)
A.E. Summers,
C.J. Whelan
and
M. Parsons
Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells. (2003)
K. Ihenetu,
A. Molleman,
M. Parsons
and
C.J. Whelan
Investigation of nicotine binding to THP-1 cells : evidence for a non-cholinergic binding site. (2001)
D. Morgan,
M. Parsons
and
C.J. Whelan